Free Trial

Aurora Cannabis (ACB) Competitors

Aurora Cannabis logo
C$7.34 +0.23 (+3.23%)
As of 10/24/2025 04:00 PM Eastern

ACB vs. CRON, THCX, DHT.UN, WEED, GUD, CPH, OGI, SUGR, FIRE, and EPI

Should you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Cronos Group (CRON), Hydropothecary (THCX), DRI Healthcare Trust (DHT.UN), Canopy Growth (WEED), Knight Therapeutics (GUD), Cipher Pharmaceuticals (CPH), Organigram (OGI), SugarBud Craft Growers (SUGR), Supreme Cannabis (FIRE), and ESSA Pharma (EPI). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Aurora Cannabis vs. Its Competitors

Cronos Group (TSE:CRON) and Aurora Cannabis (TSE:ACB) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, media sentiment, risk, profitability, dividends and analyst recommendations.

Aurora Cannabis has a consensus target price of C$8.75, suggesting a potential upside of 19.21%. Given Aurora Cannabis' stronger consensus rating and higher possible upside, analysts clearly believe Aurora Cannabis is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
4.00

In the previous week, Cronos Group had 1 more articles in the media than Aurora Cannabis. MarketBeat recorded 2 mentions for Cronos Group and 1 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 0.75 beat Cronos Group's score of 0.67 indicating that Aurora Cannabis is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cronos Group
0 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Aurora Cannabis
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cronos Group has higher earnings, but lower revenue than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos GroupC$130.28M10.41-C$32.78MC$0.0570.80
Aurora CannabisC$357.88M1.15-C$44.16M-C$0.33-22.24

Aurora Cannabis has a net margin of -22.55% compared to Cronos Group's net margin of -42.65%. Cronos Group's return on equity of -4.40% beat Aurora Cannabis' return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos Group-42.65% -4.40% -3.73%
Aurora Cannabis -22.55%-8.36%-1.87%

Cronos Group has a beta of 1.299122, indicating that its share price is 30% more volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.087815, indicating that its share price is 9% more volatile than the S&P 500.

4.5% of Cronos Group shares are owned by institutional investors. Comparatively, 4.5% of Aurora Cannabis shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Cronos Group and Aurora Cannabis tied by winning 8 of the 16 factors compared between the two stocks.

Get Aurora Cannabis News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACB vs. The Competition

MetricAurora CannabisDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$412.85MC$1.69BC$6.25BC$9.66B
Dividend YieldN/A2.95%5.72%6.50%
P/E Ratio-22.248.9031.1329.41
Price / Sales1.151,626.59560.7810.82
Price / Cash1.2510.3737.0883.29
Price / Book0.6711.2112.055.78
Net Income-C$44.16MC$20.70BC$3.33BC$301.20M
7 Day Performance-0.14%0.07%1.94%0.79%
1 Month Performance6.69%1.83%7.77%2.39%
1 Year Performance-10.92%7.11%56.40%35.08%

Aurora Cannabis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACB
Aurora Cannabis
0.4604 of 5 stars
C$7.34
+3.2%
C$8.75
+19.2%
-6.4%C$412.85MC$357.88M-22.241,073
CRON
Cronos Group
N/AC$3.52
-6.9%
N/A+16.1%C$1.35BC$130.28M70.40450News Coverage
THCX
Hydropothecary
N/AC$5.30
+6.6%
N/A+0.0%C$949.11MN/A0.00N/AHigh Trading Volume
DHT.UN
DRI Healthcare Trust
N/AC$14.38
-0.6%
C$18.88
+31.3%
+10.2%C$798.10MC$139.45M205.43N/APositive News
WEED
Canopy Growth
0.1526 of 5 stars
C$1.92
-16.5%
C$1.55
-19.3%
N/AC$599.02MC$274.92M-0.462,700High Trading Volume
GUD
Knight Therapeutics
N/AC$5.77
-2.0%
C$7.15
+23.9%
+4.1%C$575.00MC$384.56M-21.70725
CPH
Cipher Pharmaceuticals
0.5619 of 5 stars
C$14.25
-2.2%
C$14.75
+3.5%
-10.3%C$361.86MC$47.59M30.985
OGI
Organigram
3.0036 of 5 stars
C$2.66
-6.3%
C$3.33
+25.0%
-1.2%C$356.13MC$223.82M221.67987High Trading Volume
SUGR
SugarBud Craft Growers
N/AC$11.27
-6.1%
N/A+29.0%C$268.40MC$718.29M19.7644Gap Up
FIRE
Supreme Cannabis
N/AN/AN/AN/AC$259.40MC$53.29M-10.97400Positive News
EPI
ESSA Pharma
N/AC$8.20
+7.2%
N/A+0.0%C$237.87MN/A-8.2725

Related Companies and Tools


This page (TSE:ACB) was last updated on 10/25/2025 by MarketBeat.com Staff
From Our Partners